估算 2022 年 1 月 1 日至 3 月 16 日在纽约市（NYC）奥密克戎（BA.1）疫情期间严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的流行期。
Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022.
机构信息
Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, New York, USA.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, New York, USA.
出版信息
Clin Infect Dis. 2023 Feb 8;76(3):e499-e502. doi: 10.1093/cid/ciac644.
Abstract
In a population-based survey of adults in New York City, we assessed positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (including via exclusive at-home testing) and possible cases among untested respondents. An estimated 27.4% (95% confidence interval [CI]: 22.8%-32.0%) or 1.8 million adults (95% CI: 1.6-2.1 million) had SARS-CoV-2 infection between 1 January and 16 March 2022.
摘要
在一项针对纽约市成年人的基于人群的调查中，我们评估了阳性严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）检测（包括通过独家家庭检测）和未检测受访者中的可能病例。估计有 27.4%（95%置信区间[CI]：22.8%-32.0%）或 180 万成年人（95%CI：1.6-2.1 百万）在 2022 年 1 月 1 日至 3 月 16 日期间感染了 SARS-CoV-2。
相似文献
1
Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022.估算 2022 年 1 月 1 日至 3 月 16 日在纽约市（NYC）奥密克戎（BA.1）疫情期间严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的流行期。
Clin Infect Dis. 2023 Feb 8;76(3):e499-e502. doi: 10.1093/cid/ciac644.
2
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.2022年4月至5月纽约市BA.2/BA.2.12.1疫情激增期间的新冠病毒感染流行率及其他公共卫生结果
Commun Med (Lond). 2023 Jun 30;3(1):92. doi: 10.1038/s43856-023-00321-w.
3
Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.2020 年 6 月至 10 月期间纽约市成年人中 SARS-CoV-2 抗体的流行情况：一项基于人群的调查。
J Infect Dis. 2021 Jul 15;224(2):188-195. doi: 10.1093/infdis/jiab296.
4
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.2020 年 9 月至 2021 年 3 月期间，纽约市基于人群的调查：分阶段接种疫苗期间 SARS-CoV-2 抗体的流行率。
Epidemiol Infect. 2022 May 18;150:e105. doi: 10.1017/S0950268822000875.
5
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率：基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.
6
The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022.2022 年 6 月至 7 月，美国成年人在 BA.4/BA.5 浪潮期间 SARS-CoV-2 感染和长新冠的流行情况。
Prev Med. 2023 Apr;169:107461. doi: 10.1016/j.ypmed.2023.107461. Epub 2023 Feb 20.
7
SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City.挪威鼠（褐家鼠）在纽约市的 SARS-CoV-2 暴露情况。
mBio. 2023 Apr 25;14(2):e0362122. doi: 10.1128/mbio.03621-22. Epub 2023 Mar 9.
8
The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022.将家庭检测纳入 SARS-CoV-2 时点患病率估计的重要性：来自美国全国队列的研究结果，2022 年 2 月。
JMIR Public Health Surveill. 2022 Dec 27;8(12):e38196. doi: 10.2196/38196.
9
Association between regional distributions of SARS-CoV-2 seroconversion and out-of-hospital sudden death during the first epidemic outbreak in New York.纽约首次 SARS-CoV-2 血清转换的地区分布与院外猝死之间的关联。
Heart Rhythm. 2021 Feb;18(2):215-218. doi: 10.1016/j.hrthm.2020.11.022.
10
Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance and Exposure in the Perioperative Setting With Universal Testing and Personal Protective Equipment Policies.严重急性呼吸综合征冠状病毒 2 监测和围手术期暴露，采用通用测试和个人防护设备政策。
Clin Infect Dis. 2021 Nov 2;73(9):e3013-e3018. doi: 10.1093/cid/ciaa1607.
引用本文的文献
1
Tracking COVID-19 Infections Using Survey Data on Rapid At-Home Tests.利用快速家庭检测的调查数据追踪 COVID-19 感染。
JAMA Netw Open. 2024 Sep 3;7(9):e2435442. doi: 10.1001/jamanetworkopen.2024.35442.
2
Self-tests for COVID-19: What is the evidence? A living systematic review and meta-analysis (2020-2023).新冠病毒自我检测：证据有哪些？一项实时系统评价与荟萃分析（2020 - 2023年）
PLOS Glob Public Health. 2024 Feb 7;4(2):e0002336. doi: 10.1371/journal.pgph.0002336. eCollection 2024.
3
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.美国成年人社区前瞻性队列研究中疫苗接种前和接种期间 SARS-CoV-2 感染的血清学发生率。
Sci Rep. 2024 Jan 5;14(1):644. doi: 10.1038/s41598-023-51029-9.
4
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.在美国成年人社区前瞻性队列中，疫苗推出之前及期间SARS-CoV-2感染的血清学发病率。
medRxiv. 2023 Oct 2:2023.09.29.23296142. doi: 10.1101/2023.09.29.23296142.
5
"Boosting" Surveillance for a More Impactful Public Health Response During Protracted and Evolving Infectious Disease Threats: Insights From the COVID-19 Pandemic.在长期且不断演变的传染病威胁期间加强监测以实现更有效的公共卫生应对：来自新冠疫情的见解
Health Secur. 2023 Sep;21(S1):S47-S55. doi: 10.1089/hs.2023.0046. Epub 2023 Aug 29.
6
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.2022年4月至5月纽约市BA.2/BA.2.12.1疫情激增期间的新冠病毒感染流行率及其他公共卫生结果
Commun Med (Lond). 2023 Jun 30;3(1):92. doi: 10.1038/s43856-023-00321-w.
7
Comparison of COVID-19 home-testers vs. laboratory-testers in New York State (excluding New York City), November 2021 to April 2022.2021 年 11 月至 2022 年 4 月期间，纽约州（不包括纽约市）的 COVID-19 家庭检测与实验室检测对比。
Front Public Health. 2023 Mar 23;11:1058644. doi: 10.3389/fpubh.2023.1058644. eCollection 2023.
8
The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022.2022 年 6 月至 7 月，美国成年人在 BA.4/BA.5 浪潮期间 SARS-CoV-2 感染和长新冠的流行情况。
Prev Med. 2023 Apr;169:107461. doi: 10.1016/j.ypmed.2023.107461. Epub 2023 Feb 20.
9
Effect of Masking to Prevent COVID-19 Transmission in Schools and the Responsibility of States to Protect Public Health.口罩在预防学校新冠病毒传播中的作用及国家保护公众健康的责任
Am J Public Health. 2022 Dec;112(12):1696-1698. doi: 10.2105/AJPH.2022.307125.
10
Comparative hospitalization risk for SARS-CoV-2 Omicron and Delta variant infections, by variant predominance periods and patient-level sequencing results, New York City, August 2021-January 2022.2021 年 8 月至 2022 年 1 月期间，纽约市按变异主导期和患者测序结果比较 SARS-CoV-2 奥密克戎和德尔塔变异感染的住院风险。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13062. doi: 10.1111/irv.13062. Epub 2022 Oct 31.
Zotero 插件